Targeting of Immune Cells by Dual TLR2/7 Ligands Suppresses Features of Allergic Th2 Immune Responses in Mice

Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses

(2017) Alice Gutjahr et al.   JOURNAL OF IMMUNOLOGY

Epicutaneous immune modulation with Bet v 1 plus R848 suppresses allergic asthma in a murine model

(2013) S. Siebeneicher et al.   ALLERGY

A specific role for TLR1 in protective TH17 immunity during mucosal infection

(2012) R. William DePaolo et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Mechanisms of allergen-specific immunotherapy

(2012) Hiroyuki Fujita et al.   Clinical and Translational Allergy

Treatment with the TLR7 agonist R848 induces regulatory T-cell-mediated suppression of established asthma symptoms

(2011) Linh Pham Van et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Oral tolerance induction does not resolve gastrointestinal inflammation in a mouse model offoodallergy

(2011) Manja Burggraf et al.   MOLECULAR NUTRITION & FOOD RESEARCH

TLR2 Agonists Enhance CD8+Foxp3+ Regulatory T Cells and Suppress Th2 Immune Responses during Allergen Immunotherapy

(2010) Y.-G. Tsai et al.   JOURNAL OF IMMUNOLOGY

Fusion protein of TLR5-ligand and allergen potentiates activation and IL-10 secretion in murine myeloid DC

(2010) Stefan Schülke et al.   MOLECULAR IMMUNOLOGY

TLR-based immune adjuvants

(2010) Folkert Steinhagen et al.   VACCINE

Engagement of TLR2 Does not Reverse the Suppressor Function of Mouse Regulatory T Cells, but Promotes Their Survival

(2009) Q. Chen et al.   JOURNAL OF IMMUNOLOGY

IMIQUIMOD, A TOLL-LIKE RECEPTOR 7 LIGAND, INHIBITS AIRWAY REMODELLING IN A MURINE MODEL OF CHRONIC ASTHMA

(2008) Qiang Du et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY